$VTGN

VistaGen Therapeutics Inc

  • NASDAQ
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$0.15 ▲3.878%

Extented Hours

VOLUME

3,322,845

DAY RANGE

0.135 - 0.148

52 WEEK

0.0768 - 1.79

Join Discuss about VTGN with like-minded investors

See 3 more VTGN posts
profile
@dros #droscrew
recently

RECAP 7/8 Unusual Calls: $DISH Jul 19 C $CLVS Jul 3 C $WDC Sep 60 C $MULN Jul 1.5 C $KSS Aug 42.5 C $SNAP Jan-24 50 C $VTGN Nov 1/2.5 C Spd $BIRD Dec 7.5 C $TECK Aug 30 C $OXY Jan 70 C $DDOG Jan 130 C $ARVL Sep 2.5 C

74 Replies 9 👍 11 🔥

profile
@dros #droscrew
recently

RECAP 6/27 Unusual Calls $BITO Jun30 14 C $TQQQ Jul08 35 C $DISH Jul08 20 C $HOOD Jul01 9 C $EWG Jul 24.75 C $ASHR Jul 35 C $LAZR Aug 10 C $C Sep 55/62.5 C Spd $RBLX Oct 75 C $CRK Jul 15 C $VAL Aug 50/60 C Spd $MRK Jul01 96 C $CHPT Jul08 16/19 C Spd $SABR Aug 8 C $DAL Aug 35 C $WOW Aug 17.5 C $VTGN Aug 1/2.5 C Spd $DNA Aug 3.5 C $HOOD Jan 20 C $FXI Jul 35 C $KRE Dec 73 C

146 Replies 11 👍 7 🔥

Load more...

Key Metrics

Market Cap

30.46 M

Beta

1.78

Avg. Volume

4.52 M

Shares Outstanding

219.33 M

Yield

0%

Public Float

0

Next Earnings Date

2023-06-22

Next Dividend Date

Company Information

VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing and commercializing innovative medicines with the potential to go beyond the current standard of care for anxiety, depression, and other CNS disorders. Each of VistaGen's three drug candidates has a differentiated potential mechanism of action, has been well-tolerated in all clinical studies to date, and has therapeutic potential in multiple CNS markets.

Website:

HQ: ,

Related News